A recent survey of over 2,000 U.S. consumers by Elanco Animal Health shows that 93% of pet owners have maintained or increased their spending on pet health in the past three months, despite cost-of-living challenges. The survey highlights that pet health remains a protected priority, with 32% increasing spend recently and 93% expecting to maintain or increase it over the next year. Pet owners increasingly view their pets' wellbeing as vital, often prioritizing it over other expenses. The study also reveals a shift in how pet medications are purchased, with more owners using diverse channels beyond veterinary clinics. Future pet demand is strong, with many planning to adopt new pets soon. This trend underscores the resilience and growth potential of the pet health sector.
Elanco Animal Health's market cap stands at $11.83 billion as of Nov 06, 2026 18:41 WIB, reflecting strong investor interest in the pet health sector. The stock price on Pluang is USD 25.28, showing a notable 6.80% increase in one day, supported by a daily volume of 6,709,776 shares. This trading activity aligns with the survey's indication of sustained and growing consumer spending on pet health.
Elanco Animal Health posted Q3 2026 revenue of $1.265 billion, up 11% year-over-year with 9% organic growth, driven by strong demand for products like Zenrelia and Credelio Quattro. The company raised its full-year 2026 revenue guidance to $5.155-$5....
On November 6, Moderna, Humana, and Elanco will release earnings reports that could impact their stock rallies. Humana's Medicare Advantage update is crucial for retirees, with a focus on medical costs and membership trends. Elanco faces supply chall...
